广西南宁市蓝添化工有限公司

Headquarter: Chemical Industry Park, Economic Development Zone,  JiNan City,  ShanDong Province, China.

Phone +86-152 8958 7728

Angela@BlueSkytcca.com

Japan demonstrates ability of chlorine dioxide aqueous solution to … – BSA bureau


11 June 2021 | News
Solution Also Effective against Alpha and Gamma Variants of SARS-CoV-2
Image credit- shutterstock.com
Taiko Pharmaceutical based in Osaka, Japan, has announced that long-lasting chlorine dioxide (ClO2) aqueous solution inactivated over 99.99% of SARS-CoV-2 (COVID-19 Virus), including its Alpha and Gamma variants, in a test conducted in collaboration with Kitasato Institute/Kitasato University in Tokyo, Japan.
SARS-CoV-2 strains were mixed with Taiko Pharmaceutical’s long-lasting ClO2 aqueous solution at the ratio of 1:19 (154 ppm in aqueous solution remained active for three years’ storage) and the infectivity titer was determined by the plaque assay at 10 sec and 60 sec using TMPRSS2-expressing Vero E6 cells. The results revealed that the ClO2 aqueous solution inactivated over 99.99% of SARS-CoV-2, including the two variant strains.
The Alpha and Gamma variants of SARS-CoV-2 contain N501Y and E484K mutation, respectively, and these were suggested to affect, respectively, the infection/transmission potency, and antigenic drift. Currently, worldwide dissemination of the N501Y variant has been confirmed.
A study reported that ClO2 denatures the spike protein on the surface of SARS-CoV-2 and inhibits its binding to the human ACE2 receptor. The current study adds invaluable information for the effectiveness of long-lasting ClO2 aqueous solution in disinfecting the coronaviruses.
Rise of Middle East as a Bi…
Is APAC Edging Closer to Cl…
“The better the AI gets, th…
“Lunit is poised to evolve …
What's Transforming Australia's Thr
“By harnessing the power of single-
Thailand Hub of Talents in Cancer I
Sartorius forms partnership with SP
Australian govt invests $35 M to de
Merck announces two strategic colla
Partnership in Korea to advance 3D
Agilent partners with National Canc
Is the Big Pharma setting sights on Middle East?

1 North Bridge Road,
#08-08 High Street Centre,
Singapore 179094

Email : communications@biospectrumasia.com

+65 90150305
Visit Our Digital Magazine :
BioSpectrum India
NuFFooDS Spectrum
Privacy Policy
Sitemap
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer
Web Interface Conceived and Powered By : SCI Knowledge Interlinks

source

Leave a Reply

Your email address will not be published.

*